Aronow, Wilbert S.

2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension

Blood Pressure and Hypertension StudiesClinical practice guidelines implementation

Cited by 7,391

2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults

Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology

Blood Pressure and Hypertension StudiesClinical practice guidelines implementation

Cited by 6,616

2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension

Blood Pressure and Hypertension StudiesClinical practice guidelines implementation

Cited by 4,347

2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Circulation

Blood Pressure and Hypertension StudiesClinical practice guidelines implementation

Cited by 1,127

Effects of Digoxin on Morbidity and Mortality in Diastolic Heart Failure: The Ancillary Digitalis Investigation Group Trial

Ahmed, A., Rich, M. W., Fleg, J. L., Zile, M. R., Young, J. B., Kitzman, D. W., Love, T. E., Aronow, W. S., Adams, K. F., & Gheorghiade, M. (2006) · Circulation

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 605

Effects of Quercetin on Blood Pressure: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials

Serban, M., Sahebkar, A., Zanchetti, A., Mikhailidis, D. P., Howard, G., Antal, D., Andrica, F., Ahmed, A., Aronow, W. S., Muntner, P., et al. (2016) · Journal of the American Heart Association

Phytochemicals and Antioxidant ActivitiesBlood Pressure and Hypertension Studies

Cited by 317

Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial

Gheorghiade, M., Fonarow, G. C., van Veldhuisen, D. J., Cleland, J. G. F., Butler, J., Epstein, A. E., Patel, K., Aban, I. B., Aronow, W. S., Anker, S. D., et al. (2013) · European Heart Journal

Atrial Fibrillation Management and OutcomesHeart Failure Treatment and Management

Cited by 192

Cardiovascular drug therapy in the elderly: benefits and challenges

Fleg, J. L., Aronow, W. S., & Frishman, W. H. (2011) · Nature Reviews Cardiology

Pharmaceutical Practices and Patient OutcomesBlood Pressure and Hypertension Studies

Cited by 186

Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel: This paper is also published in parallel in Archives of Medical Science [Banach M, Rizzo M, Toth PP, et al. Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel. Arch Med Sci 2015; 11(1): 1–23]

Banach, M., Rizzo, M., Toth, P. P., Farnier, M., Davidson, M. H., Al-Rasadi, K., Aronow, W. S., Athyros, V., Djuric, D. M., Ezhov, M. V., et al. (2015) · Expert Opinion on Drug Safety

Lipoproteins and Cardiovascular HealthPharmacovigilance and Adverse Drug Reactions

Cited by 162

Incidence of heart failure in 2,737 older persons with and without diabetes mellitus

Aronow, W. S., & Ahn, C. (1999) · Chest

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 144

Heart disease and aging

Aronow, W. S. (2006) · Medical Clinics of North America

Cardiovascular Function and Risk FactorsCardiovascular Health and Risk Factors

Cited by 68

Renin-angiotensin system inhibition and lower 30-day all-cause readmission in Medicare beneficiaries with heart failure

Sanam, K., Bhatia, V., Bajaj, N. S., Gaba, S., Morgan, C. J., Fonarow, G. C., Butler, J., Deedwania, P., Prabhu, S. D., Wu, W.-C., et al. (2016) · The American Journal of Medicine

Heart Failure Treatment and ManagementRenin-Angiotensin System Studies

Cited by 50

Cardiovascular benefits and safety of non-insulin medications used in the treatment of type 2 diabetes mellitus

Yandrapalli, S., Jolly, G., Horblitt, A., Sanaani, A., & Aronow, W. S. (2017) · Postgraduate Medicine

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 50

Etiology of Syncope in Patients Hospitalized With Syncope and Predictors of Mortality and Rehospitalization for Syncope at 27‐Month Follow‐Up

Sule, S., Palaniswamy, C., Aronow, W. S., Ahn, C., Peterson, S. J., Adapa, S., & Mudambi, L. (2011) · Clinical Cardiology

Cardiovascular Syncope and Autonomic DisordersHeart Failure Treatment and Management

Cited by 35

Prevalence of atherothrombotic brain infarction, coronary artery disease and peripheral arterial disease in elderly blacks, Hispanics and whites

Aronow, W. S. (1992) · The American Journal of Cardiology

Peripheral Artery Disease ManagementAcute Ischemic Stroke Management

Cited by 32

Prevalence of Left Ventricular Hypertrophy in Persons With and Without Obstructive Sleep Apnea

Sukhija, R., Aronow, W. S., Sandhu, R., Kakar, P., Maguire, G. P., Ahn, C., & Lehrman, S. G. (2006) · Cardiology in Review

Obstructive Sleep Apnea ResearchCardiovascular Function and Risk Factors

Cited by 25

Use of Statins for Primary Prevention: Selection of Risk Threshold and Implications Across Race and Gender

Goyal, A., Cooper, H. A., Aronow, W. S., Nagpal, P., Yandrapalli, S., Nabors, C. C., & Frishman, W. H. (2018) · The American Journal of Medicine

Lipoproteins and Cardiovascular HealthHealth Promotion and Cardiovascular Prevention

Cited by 6

Cardiovascular Effects of Cannabinoids

Wang, A., Dey, S., Subhan, S., Patel, J., Frishman, W. H., & Aronow, W. S. (2025) · Cardiology in Review

Cannabis and Cannabinoid ResearchCardiac Health and Mental Health

Cited by 6

Orforglipron: A Novel Oral GLP-1 Agonist for the Treatment of Obesity and Diabetes

Pillai, A. A., Sharma, A. M., Krayem, H., Frishman, W. H., & Aronow, W. S. (2025) · Cardiology in Review

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 3